• HELP
  • FAQs
  • INTRANET

Uganda Virus Research Institute

REPUBLIC OF UGANDA

News Updates

Locally Designed Adenovector Backbone to Drive Crimean Congo Hemorrhagic Fever Vaccine Development

Group photo of the participants

Researchers in Uganda have made significant strides in vaccine development using a novel adenovector backbone that was previously developed during the COVID-19 pandemic, using funds from the government of Uganda. The developed backbone is an open system that can be used in the development of other vaccines for infectious diseases.

Pages